TARRYTOWN, N.Y. and CAMBRIDGE, Mass., March 16, 2020 /PRNewswire/ -- U.S. Phase 2/3 trial initiated and will begin enrolling patients immediatelyRegeneron is leading U.S. trials, Sanofi will lead upcoming ex-U.S. trials

BALTIMORE, Md., March 16, 2020 /PRNewswire/ -- Newswise -- Researchers at the University of Maryland School of Medicine's Institute of Human

SOUTH SAN FRANCISCO, Calif., March 16, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced new data reinforcing the value of Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], the first and only FDA-approved reversal agent for the Factor Xa inhibitors rivaroxaban or apixaban. Th

SAVANNAH, Ga., March 16, 2020 /PRNewswire/ -- As part of President Trump's mandate for hospitals and locations frequented by high risk individuals to construct an emergency management plan, Royal Restrooms is reserving restrooms for the highest priority clients.  Locations such as nursing homes, medical facilities, and childcare providers are currently taking p

SANTA MONICA, Calif., March 16, 2020 /PRNewswire/ -- Today, Headspace, a global leader in mindfulness and meditation, announced that it will be providing free Headspace Plus subscriptions to healthcare professionals working in public health settings in the US through 2020 to address rising levels of stress and burnout. Headspace will also be unlocking the free, specially

CAMBRIDGE, Mass. and TARRYTOWN, N.Y., March 16, 2020 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc today announced they have started a clinical program evaluating Kevzara® (sarilumab) in patients hospitalized with severe COVID-19. Kevzara is a fully-human monoclonal antibody that inhibits the interleukin-6 (IL-6

BOSTON, March 16, 2020 /PRNewswire/ -- XRHealth, the leader in extended reality and therapeutic applications, announced the first Virtual Reality (VR) telehealth support groups for people in is

SOUTH PLAINFIELD, N.J., March 16, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Marcio Souza, Chief Operating Officer, has resigned and will be leaving the company by April 25th, 2020."We are grateful to Marcio for the significant contributions he has mad

NEW YORK, March 16, 2020 /PRNewswire/ -- Bridge Medicines and The Rockefeller University today announced an exclusive license agreement to develop novel inhibitors of ENL-YEATS for the treatment of acute leukemias such as Acute Myelogenous Leukemia (AML) and potentially solid tumors.  ENL-YEATS is an epigenetic "reader" protei

BOCA RATON, Fla., March 16, 2020 /PRNewswire/ -- Digital health and supply chain entrepreneurs Randy Parker and Glenn Nussdorf today announced the launch of Genius Rx, a full-service, fully automated digital pharmacy that will use proprietary technology to make pharmacy services simple, intuitive and personal